University hosts Open Innovation workshop in China
4 November 13
The University of Bradford in partnership with AstraZeneca is to host an Open Innovation workshop in Guangzhou, China, in November 2013.
The workshop will bring together Chinese companies and academic scientists with leading European researchers and entrepreneurs in order to create novel ‘Drug Delivery’ solutions, to ensure that medicines perform better in patients suffering from cardiovascular and metabolic diseases and cancer.
The week-long event, from the 4 to 8 November, will allow participants time to explore ideas, visit facilities and define innovative new collaborative projects which will be expected to contribute to improved health outcomes in patients .
Twelve carefully-selected entrepreneurial scientists from industry and academia in Europe, will meet with twelve similarly-recruited scientists from China, in order to generate ideas for new technologies, products and start-up companies which will then be funded by Chinese provincial government (in Guangzhou).
Paul Thorning, Director of Open Innovation at the University of Bradford, realises the full potential of the workshop: “We believe this is an unparalleled opportunity to create meaningful links and generate value through innovation with China.
“The experts chosen will work together through a carefully facilitated process, with full translation support, to define potential projects which can be expected to deliver some form of financial return within 3-4 years. Considerable follow-on funding support is available in China for successful projects.”
For the past seven years, the University has been running a rapidly-expanding collaborative research and technology development programme across China. To date the Bradford team have formal links with over 50 Chinese institutions, and have secured over £15m of collaborative funding in China and in the UK.
The open innovation programme run by the University of Bradford with China is seen as a model of excellence in international collaboration in technology development and transfer. The team have previously run six similar workshops resulting in 22 funded projects (other applications pending).
Marcel de Matas, a Principal Scientist with AstraZeneca, said: “AstraZeneca is proud to sponsor the seventh workshop. Our focus is on developing new medicines that make a meaningful difference to patients’ lives; with a philosophy of innovation and collaboration we can achieve better health for all. To succeed now and in the future, we know that we will have to continue investing and actively seek strategic partnerships outside our own laboratories.”
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. In sponsoring the workshop, AstraZeneca seeks to further develop its scientific network in China and to see new projects generated in areas of specific interest, which may present opportunities for future scientific collaborations in the quest to bring new medicines to patients.
4 November 13
Further information for Media Enquirers
For further information please contact the University of Bradford Press Office on 01274 23 3089/3084.
Out of office hours call 07879 437996. Alternatively, e-mail firstname.lastname@example.org or fax on (01274) 236280.